Ion-Doped Iron-Based nanoparticles with enhanced magnetic properties: Synthesis and formation mechanism via coprecipitation
Source abstract
Abstract
Iron-based magnetic nanoparticles have gained significant attention in biomedicine. However, the magnetic properties of iron-based nanoparticles prepared through coprecipitation methods often do not meet application requirements. This study aims to enhance the performance of iron-based magnetic nanoparticles by synthesizing them via the coprecipitation method and doping them with Mn 2+, Zn 2+, and Co 2+ ions in various ratios. Among these, Zn-doped nanoparticles with a 0.6 ratio (ZION-6) exhibits the highest saturation magnetization intensity of 98 emu/g sample and the highest r 2 values of 165.2 mM −1·s −1, making them an effective T 2 MRI contrast agent. Our investigation into the coprecipitation process revealed a formation mechanism for ion-doped magnetic iron-based nanoparticles. This mechanism involves the formation of an intermediate phase, α-FeOOH, followed by phase transformation, ion doping, and the aggregation of small particles to yield the final magnetic nanoparticles. This research could pave the way for developing magnetic nanoparticles with improved properties for biomedical applications.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Magnetic iron oxide nanoparticle (IONP) synthesis to applications: present and future10.3390/ma13204644 ↗
2. Magnetic iron oxide: preparation and characterization for antibacterial activity applications10.1007/s10971-023-06300-w ↗
3. Magnetic nanoparticles: synthesis, anisotropy, and applications10.1021/acs.chemrev.1c00860 ↗
4. Advances in atherosclerosis theranostics harnessing iron oxide-based nanoparticles10.4028/b-wjQRP6 ↗
5. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia10.1016/j.actbio.2019.07.017 ↗
6. Evaluating PVP coated iron oxide particles for localized magnetic hyperthermia and MRI imaging10.1007/s00339-024-07452-4 ↗
7. Small zinc doped iron oxide tracers for magnetic particle imaging
8. Optimization of iron oxide nanoparticles for MRI-guided magnetic hyperthermia tumor therapy: reassessing the role of shape in their magnetocaloric effect10.1039/D3TB01821K ↗
9. SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer10.1007/s10544-024-00698-y ↗
10. Utilization of superparamagnetic iron oxide nanoparticles (SPIONs) as a vector for drug delivery10.1007/s13204-023-02853-y ↗
11. Controllable fabrication of multi-modal porous PLGA scaffolds with different sizes of SPIONs using supercritical CO2 foaming10.1002/app.52287 ↗
12. Multi-modal cell structure formation of poly (lactic-co-glycolic acid)/superparamagnetic iron oxide nanoparticles composite scaffolds by supercritical CO2 varying-temperature foaming10.1002/pat.5650 ↗
13. Iron oxides based nanozyme sensor arrays for the detection of active substances in licorice10.1016/j.talanta.2023.124407 ↗
14. Iron oxide nanoparticles: The precise strategy for targeted delivery of genes, oligonucleotides and peptides in cancer therapy
15. Ultra-large-scale syntheses of monodisperse nanocrystals10.1038/nmat1251 ↗
16. Magnetic particle imaging in vascular imaging, immunotherapy, cell tracking, and noninvasive diagnosis10.1155/2023/4131117 ↗
17. The promise of metal-doped iron oxide nanoparticles as antimicrobial agent10.1021/acsomega.3c06323 ↗
18. Application of biocompatible and ultrastable superparamagnetic iron(iii) oxide nanoparticles doped with magnesium for efficient magnetic fluid hyperthermia in lung cancer cells10.1039/D3TB00167A ↗
19. Biocompatible magnetic fluids of Co-doped iron oxide nanoparticles with tunable magnetic properties10.3390/nano10061019 ↗
20. Zn doped iron oxide nanoparticles with high magnetization and photothermal efficiency for cancer treatment10.1039/D2TB01338J ↗
21. Surface manganese substitution in magnetite nanocrystals enhances T1 contrast ability by increasing electron spin relaxation10.1039/C7TB02954C ↗
22. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control10.1039/C4NR02680B ↗
23. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles10.1002/anie.200805149 ↗
24. Progress and prospects of magnetic iron oxide nanoparticles in biomedical applications: a review10.1111/aor.14027 ↗
25. Synthesis of iron-based magnetic nanocomposites: a review10.1016/j.arabjc.2021.103301 ↗
26. Synthesis, characterizations, and applications of Fe3O4 and Co-doped Fe3O4 nanomaterials10.1007/s13538-024-01469-z ↗
27. Temperature effects on the structural, morphological, and magnetic properties of iron oxide nanoclusters using solvothermal method
28. Size control of iron oxide nanoparticles synthesized by thermal decomposition methods10.1021/acs.jpcc.2c05380 ↗
29. Synthesis of iron oxide nanoparticles by thermal decomposition of cryochemically modified precursors, Mosc Univ Chem
30. Structure switch between α-Fe2O3, γ-Fe2O3 and Fe3O4 during the large scale and low temperature sol-gel synthesis of nearly monodispersed iron oxide nanoparticles10.1016/j.apt.2012.03.001 ↗
31. Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents10.1039/C5NR03867G ↗
32. Adaptive iron-based magnetic nanomaterials of high performance for biomedical applications10.1007/s12274-021-3546-1 ↗
33. Biotransformation and toxicity evaluation of functionalized manganese doped iron oxide nanoparticles10.1002/jbm.b.34815 ↗
34. Revealing the crystal phases of primary particles formed during the coprecipitation of iron oxides10.1039/D2CC01617F ↗
35. Substituting chromium in iron-based catalysts for the high-temperature water-gas shift reaction10.1021/acscatal.2c03871 ↗
36. Highly nanocrystalline Mg doped ZnFe2O4 powders for rapid and simultaneous adsorption of lead, copper, and cadmium heavy metals ions in synthetic/sea waters10.1016/j.jallcom.2023.173297 ↗
37. Composition tunable manganese ferrite nanoparticles for optimized contrast ability10.1021/acs.chemmater.7b00035 ↗
38. Engineered iron-oxide-based nanoparticles as enhanced contrast agents for efficient tumor imaging10.1021/nn305991e ↗
39. Pushing up the magnetisation values for iron oxide nanoparticles via zinc doping: X-ray studies on the particle's sub-nano structure of different synthesis routes10.1039/C6CP04221J ↗
40. Tuning the magnetic properties of metal oxide nanocrystal heterostructures by cation exchange10.1021/nl304115r ↗
41. Unravelling the growth mechanism of the co-precipitation of iron oxide nanoparticles with the aid of synchrotron X-Ray diffraction in solution10.1039/C9NR00531E ↗
42. Unveiling the formation mechanism of polydisperse iron oxide nanoparticles in coprecipitation route10.1016/j.jcrysgro.2023.127419 ↗
43. The coprecipitation formation study of iron oxide nanoparticles with the assist of a gas/liquid mixed phase fluidic reactor10.1016/j.colsurfa.2022.129107 ↗
44. Labile Fe(III) from sorbed Fe(II) oxidation is the key intermediate in Fe(II)-catalyzed ferrihydrite transformation10.1016/j.gca.2019.12.028 ↗
45. Formation pathways of magnetite nanoparticles by coprecipitation method10.1021/jp211843g ↗
46. Co-precipitation synthesis of stable iron oxide nanoparticles with NaOH: new insights and continuous production via flow chemistry10.1016/j.cej.2020.125740 ↗
47. Effect of citrate on the size and the magnetic properties of primary Fe3O4 nanoparticles and their aggregates10.3390/app11156974 ↗
48. Inductive heating enhances ripening in the aqueous synthesis of magnetic nanoparticles10.1021/acs.cgd.2c00694 ↗
49. Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug delivery10.1039/C6SC01359G ↗
50. A novel class of 1H-MRI contrast agents based on the relaxation enhancement induced on water protons by 14N-Containing imidazole moieties10.1002/anie.202011513 ↗
51. Atomic insights into the mechanisms of Al3+ or Cr3+ affecting ferrihydrite nucleation10.1039/D3RA02945J ↗
52. Optimization of different wet chemical routes and phase evolution studies of MnFe2O4 nanoparticles10.1016/j.ceramint.2019.03.114 ↗
53. Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents10.1039/C5NR03867G ↗
54. Cubic mesocrystal magnetic iron oxide nanoparticle formation by oriented aggregation of cubes in organic media: a rational design to enhance the magnetic hyperthermia efficiency10.1021/acsami.3c03254 ↗
55. Core-Shell Fe3O4@C nanoparticles as highly effective T2 magnetic resonance imaging contrast agents. in vitro and in vivo studies10.3390/nano14020177 ↗
56. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging10.1039/c3nr05550g ↗
57. Transition-metal-doped hydrophilic ultrasmall iron oxide modulates MRI contrast performance for accurate diagnosis of orthotopic prostate cancer10.1039/D2TB01860H ↗